Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAROTRECTINIB vs LATANOPROST\TIMOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAROTRECTINIB vs LATANOPROST\TIMOLOL: Safety Overview

Metric LAROTRECTINIB LATANOPROST\TIMOLOL
Total FAERS Reports 798 195
Deaths Reported 149 23
Death Rate 18.7% 11.8%
Hospitalizations 151 42
Average Patient Age 48.9 yrs 62.8 yrs
% Female Patients 51.5% 83.7%
FDA Approval Date Nov 26, 2018 N/A
Manufacturer Bayer HealthCare Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A